Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Healthcare Triangle (HCTI) EBITDA Margin (2020 - 2025)

Healthcare Triangle's EBITDA Margin history spans 6 years, with the latest figure at 143.29% for Q4 2025.

  • On a quarterly basis, EBITDA Margin rose 25776.0% to 143.29% in Q4 2025 year-over-year; TTM through Dec 2025 was 65.82%, a 4621.0% increase, with the full-year FY2025 number at 68.14%, up 4647.0% from a year prior.
  • EBITDA Margin hit 143.29% in Q4 2025 for Healthcare Triangle, down from 54.46% in the prior quarter.
  • Over the last five years, EBITDA Margin for HCTI hit a ceiling of 4.68% in Q2 2021 and a floor of 401.05% in Q4 2024.
  • Historically, EBITDA Margin has averaged 55.43% across 5 years, with a median of 34.32% in 2021.
  • Biggest five-year swings in EBITDA Margin: crashed -38218bps in 2024 and later surged 25776bps in 2025.
  • Tracing HCTI's EBITDA Margin over 5 years: stood at 36.18% in 2021, then crashed by -160bps to 94.25% in 2022, then soared by 80bps to 18.87% in 2023, then tumbled by -2026bps to 401.05% in 2024, then surged by 64bps to 143.29% in 2025.
  • Business Quant data shows EBITDA Margin for HCTI at 143.29% in Q4 2025, 54.46% in Q3 2025, and 38.19% in Q2 2025.